Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNYU Langone Health

About this trial

This is a randomized controlled study of parents of children to be discharged from the neonatal intensive care unit at Bellevue and Elmhurst hospitals. A total of 425 subjects will be recruited across two sites over preparatory phases and two primary study phases.

Eligibility criteria

Qualifiers

English or Spanish-speaking

18 years of age and older

Child discharged home with a Rx for >1 daily liquid medication (other than multivitamin)

Primary person who will administers child's medications.

Disqualifiers

Does not have a working phone number

Does not have access to internet (via computer/smartphone)

Does not have a mobile phone that receives texts.

Not able to return to the hospital for their child's follow-up visit

Trial design

Treatments tested in this trial

  • HELPix
  • HELPix+Tech

Treatment groups

425 Participants
are divided into 3 treatment groups

Sponsors and collaborators